Fortrea Holdings Inc. is a Humankind 100 company whose ranking is based on its Humankind Value, a proprietary metric that provides an estimate of the overall dollar amount a company creates for investors, consumers, employees, and society at large.
Fortrea Holdings Inc. operates as a holding company. The company, through its subsidiaries, provides Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions.
(All values are in US Dollars, where M=Million, B=Billion, T=Trillion.)
Fortrea Holdings Inc. has earned a spot in our top 100. The greatest contributors to this positive outcome are Healthcare R&D ($19.4 B), Pharmaceuticals ($9.6 B), and Economic Value ($1.9 B). The value associated with Healthcare R&D and Pharmaceuticals includes the impact of an estimated 550,000 additional years lived by people worldwide. The Humankind Value of this company can improve with reductions in Biofuel Production (-$205.8 M) and Greenhouse Gases (-$191.8 M). Healthcare R&D, Pharmaceuticals, Economic Value, Biofuel Production, and Greenhouse Gases are mostly or entirely a result of supply-chain relationships. For this firm, supply chain partners increase an already positive Humankind Value.